In simple terms, a substance generally must meet one of these requirements: It has an official USP or National Formulary monograph It is already part of an FDA-approved drug product It appears on the FDAs official 503A Bulks List The important point is this: BPC-157, TB-500, and injectable GHK-Cu are not FDA-approved drugs, and they are not currently on the formal 503A Bulks List
It is not approved for human or veterinary use and is not intended for clinical administration, therapeutic treatment, or diagnostic procedures
Rarely, and almost exclusively from injections rather than oral supplements
It lays down new collagen
Banned in Sports: The World Anti-Doping Agency (WADA) prohibits the use of TB-500
Sourcing both the fluid and delivery hardware from one manufacturer reduces compatibility concerns for IV program managers